The molecular basis of von Willebrand disease: the under investigated, the unexpected and the overlooked.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Identification of von Willebrand factor D4 domain mutations in patients of Afro-Caribbean descent: In vitro characterization.Research and practice in thrombosis and haemostasis · 2022
   Article
2. Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms.Blood advances · 2020
   Article
3. Intron retention resulting from a silent mutation in the VWF gene that structurally influences the 5' splice site.Blood · 2016
   Article
4. A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture.Medicine · 2016
   Observational
5. Additional markers for genetic diagnosis of type 3 von Willebrand disease in Indian population.The Indian journal of medical research · 2015
   Article
6. p.P2063S: a neutral VWF variant masquerading as a mutation.Annals of hematology · 2014
   Article
7. Identification and characterisation of mutations associated with von Willebrand disease in a Turkish patient cohort.Thrombosis and haemostasis · 2013
   Article

Corrections and comments

• Comment on
  An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease.2011

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as